EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 26 January 2023

News

EFPIA response to medicines shortages reports
25 January 2023

EFPIA member companies are not reporting shortages as a result of the situation in China, and where necessary have increased... Read more

Europe’s cancer community sets out best practice guide to sustainable, equitable and transformative...
25 January 2023

Smart investments in cancer care are urgently needed to alleviate demands on healthcare systems and improve access to... Read more

Blogs

A sustainable environment for a healthy population (Guest Blog)
23 January 2023 - Bengt Mattson - Andreas Häner

There is strong agreement between Bengt Mattson and Andreas Haener, chairs of the Interassociation Industry Pharmaceuticals... Read more

Boosting health in Europeans: Introducing a cardiovascular & diabetes health check
26 January 2023 - Christian Thonke - Victoria Tzouma

Health Checks are an investment in millions of lives Read more

Events

Even spaceships need a launchpad
31 January 2023 (Virtual event)

Bring the regulatory framework for innovative medicines into the future Read more

Impacts of IVDR Implementation on Patient Access to Clinical Trials
07 February 2023 (Online)

While the IVDR establishes a new regulatory framework for diagnostic tests in the EU to ensure test accuracy and patient... Read more

Time to act: Building a pharmaceutical framework fit for rare diseases
08 February 2023 (European Parliament, 60 Rue Wiertz, 1047, Bruxelles)

Join MEP Stelios Kympouropoulos in discussing the once-in-a-generation revision of the European pharmaceutical framework... Read more

ACCELERATE 2023 Annual Conference
09 February 2023 (Brussels & online)

All sessions, including Breakout Sessions, will be available for both in-person and online participants. Read more

What we are reading

Spain will help remind Europe of the lessons of Covid (in Spanish)
On 24 January 2023 (Cinco Dias | El Pais)

The country can take a leading role in European health policy during the next EU presidency. Read more

Health brief: Some human, intelligent chats
On 25 January 2023 (Euractiv)

Aneta Tyszkiewicz, senior digital & data manager at EFPIA, emphasises that AI systems designed for use in healthcare... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu